v3.25.2
Condensed Consolidated Statements of Changes in Shareholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Non-controlling Interest
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2023   299,215,160        
Beginning balance at Dec. 31, 2023 $ 283,825 $ 30 $ 2,136,870 $ (1,845,542) $ (11,751) $ 4,218
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares)   2,042        
Exercise of stock options 2   2      
Delivery of common stock underlying restricted stock units (in shares)   507,198        
Stock-based compensation 11,873   11,873      
Foreign currency translation adjustment (3,015)         (3,015)
Net Income (loss) attributable to non-controlling interest (574)       (574)  
Net income (loss) attributable to common shareholders (56,010)     (56,010)    
Ending balance (in shares) at Mar. 31, 2024   299,724,400        
Ending balance at Mar. 31, 2024 236,101 $ 30 2,148,745 (1,901,552) (12,325) 1,203
Beginning balance (in shares) at Dec. 31, 2023   299,215,160        
Beginning balance at Dec. 31, 2023 283,825 $ 30 2,136,870 (1,845,542) (11,751) 4,218
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net Income (loss) attributable to non-controlling interest (1,029)          
Net income (loss) attributable to common shareholders (81,282)          
Ending balance (in shares) at Jun. 30, 2024   329,336,621        
Ending balance at Jun. 30, 2024 254,231 $ 33 2,194,966 (1,926,824) (12,780) (1,164)
Beginning balance (in shares) at Mar. 31, 2024   299,724,400        
Beginning balance at Mar. 31, 2024 236,101 $ 30 2,148,745 (1,901,552) (12,325) 1,203
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock, net of offering costs (in shares)   28,791,969        
Issuance of common stock, net of offering costs 36,838 $ 3 36,835      
Exercise of stock options (in shares)   2,000        
Exercise of stock options 1   1      
Delivery of common stock underlying restricted stock units (in shares)   818,252        
Stock-based compensation 9,385   9,385      
Foreign currency translation adjustment (2,367)         (2,367)
Net Income (loss) attributable to non-controlling interest (455)       (455)  
Net income (loss) attributable to common shareholders (25,272)     (25,272)    
Ending balance (in shares) at Jun. 30, 2024   329,336,621        
Ending balance at Jun. 30, 2024 $ 254,231 $ 33 2,194,966 (1,926,824) (12,780) (1,164)
Beginning balance (in shares) at Dec. 31, 2024 339,144,854 339,144,854        
Beginning balance at Dec. 31, 2024 $ 180,782 $ 34 2,219,002 (2,017,796) (15,588) (4,870)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares)   2,150,631        
Exercise of stock options 2,700   2,700      
Delivery of common stock underlying restricted stock units (in shares)   244,312        
Stock-based compensation 11,868   11,868      
Foreign currency translation adjustment 5,197         5,197
Reduction in non-controlling interest 0   (4,237)   4,237  
Net Income (loss) attributable to non-controlling interest (5)       (5)  
Net income (loss) attributable to common shareholders 188,493     188,493    
Ending balance (in shares) at Mar. 31, 2025   341,539,797        
Ending balance at Mar. 31, 2025 $ 389,035 $ 34 2,229,333 (1,829,303) (11,356) 327
Beginning balance (in shares) at Dec. 31, 2024 339,144,854 339,144,854        
Beginning balance at Dec. 31, 2024 $ 180,782 $ 34 2,219,002 (2,017,796) (15,588) (4,870)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares) 2,151,631          
Net Income (loss) attributable to non-controlling interest $ (1)          
Net income (loss) attributable to common shareholders $ 180,463          
Ending balance (in shares) at Jun. 30, 2025 342,386,328 342,386,328        
Ending balance at Jun. 30, 2025 $ 400,359 $ 34 2,237,568 (1,837,333) (11,352) 11,442
Beginning balance (in shares) at Mar. 31, 2025   341,539,797        
Beginning balance at Mar. 31, 2025 389,035 $ 34 2,229,333 (1,829,303) (11,356) 327
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares)   1,000        
Exercise of stock options 0   0      
Delivery of common stock underlying restricted stock units (in shares)   845,531        
Stock-based compensation 8,235   8,235      
Foreign currency translation adjustment 11,115         11,115
Net Income (loss) attributable to non-controlling interest 4       4  
Net income (loss) attributable to common shareholders $ (8,030)     (8,030)    
Ending balance (in shares) at Jun. 30, 2025 342,386,328 342,386,328        
Ending balance at Jun. 30, 2025 $ 400,359 $ 34 $ 2,237,568 $ (1,837,333) $ (11,352) $ 11,442